Giovannoni G, et al. Treatment outcomes of daclizumab in patients at high risk of transitioning to secondary progressive multiple sclerosis in DECIDE. EAN 2107, O2113.
Neurofilament light en Alzheimer
mrt 2017 | Dementie
jan 2024 | Neuro-vasculair
dec 2023 | Bewegingsstoornissen